Purchases and Sales Made in Q2 2024 in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during Q2 2024. The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-123K- 22.22% |
$1.3M - $2.2M
|
430K
$2.36M
|
|
Aug 07, 2024
Q2 2024
|
Cowen And Company, LLC
|
SELL
|
- |
-219K- 50.53% |
$2.32M - $3.92M
|
214K
$1.17M
|
|
Aug 14, 2024
Q2 2024
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-236K- 58.0% |
$2.5M - $4.23M
|
171K
$937K
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-269K- 68.59% |
$2.85M - $4.82M
|
123K
$675K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-294K- 87.25% |
$3.11M - $5.25M
|
42.9K
$235K
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-299K- 36.84% |
$3.16M - $5.35M
|
513K
$2.81M
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-416K- 44.97% |
$4.4M - $7.45M
|
509K
$2.79M
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-635K- 99.03% |
$6.72M - $11.4M
|
6.2K
$34K
|
|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1M- 97.39% |
$10.6M - $18M
|
26.9K
$147K
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-2.02M- 44.94% |
$21.4M - $36.2M
|
2.47M
$13.6M
|
|
Aug 13, 2024
Q2 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-4.71M- 99.17% |
$49.9M - $84.4M
|
39.6K
$217K
|